ID
42199
Beschreibung
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Link
https://clinicaltrials.gov/show/NCT01255046
Stichworte
Versionen (3)
- 30.08.15 30.08.15 -
- 13.04.21 13.04.21 - Dr. rer. medic Philipp Neuhaus
- 18.11.21 18.11.21 -
Hochgeladen am
13. April 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Beschreibung
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0024485
- UMLS CUI [1,2]
- C0040405
- UMLS CUI [1,3]
- C0587081
Beschreibung
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0007682
Beschreibung
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0004936
Beschreibung
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
Beschreibung
patient with a history of hypersensitivity to study drugs;
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0013182
Beschreibung
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3843040
Beschreibung
participation in any research study within the last 30 days;
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0008976
Beschreibung
patient with significant alcohol or drug abuse as judged by the investigator.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0237123
Ähnliche Modelle
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
CL386174 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0234387 (UMLS CUI [1,2])